Chang‐Koo Shim
About
In The Last Decade
Chang‐Koo Shim
176 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 141
- Pharmaceutical Science 1.9k
- Molecular Biology 1.4k
- Biomaterials 1.0k
- Oncology 898
- Biomedical Engineering 501
Countries citing papers authored by Chang‐Koo Shim
This map shows the geographic impact of Chang‐Koo Shim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Koo Shim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Koo Shim more than expected).
Fields of papers citing papers by Chang‐Koo Shim
This network shows the impact of papers produced by Chang‐Koo Shim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Koo Shim. The network helps show where Chang‐Koo Shim may publish in the future.
Co-authorship network of co-authors of Chang‐Koo Shim
This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Koo Shim. A scholar is included among the top collaborators of Chang‐Koo Shim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Koo Shim. Chang‐Koo Shim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 99 | |
| 2 | 2 | |
| 3 | 52 | |
| 4 | 3 | |
| 5 | The History of Pharmacy in Korea | 1 |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 11 | |
| 9 | Guideline for Bioequivalence Studies of Generic Products in Japan | 3 |
| 10 | Statatistical Analysis of Three Sequence-Three Periods Bioequivalence Study : Application to Bioequivalence Test of Ondansetron Formulations | 0 |
| 11 | Development of $K-BEtest^{\circledR}$, a Computer Program for the Analysis of Bioequivalence | 2 |
| 12 | THE EFFECTS OF TETRACYCLINE-CONTAINING GEL ON GINGIVAL CREVICULAR ENZYME ACTIVITY | 1 |
| 13 | Damage of Omeprazole Suppository on Rectal Mucosa of Rats | 1 |
| 14 | Effect of Arginine or Sodium Phosphate Dibasic on the Stability of Omeprazole in Aqueous Solution | 1 |
| 15 | HPLC Determination of Diltiazem and Deacetyldiltiazem in Rat Plasma | 1 |
| 16 | Effect of Tween 20 on the Penetration of Ketoprofen through Excised Rat Skin | 2 |
| 17 | Mechanisms of Multiple Peak Phenomenon in the Plasma Profile of Drugs Following Oral Administration | 1 |
| 18 | HPLC Assay and Renal Excretion Characteristics of Theophylline and Its Metabolites in Rat | 1 |
| 19 | Preparation of Furosemide Retard Tablets Using Hydroxyethylcellulose as Matrix Forming Material | 0 |
| 20 | Effect of Sodium Taurodeoxycholate on Biliary Excretion of Amaranth as an Anionic Model Drug in Rats | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.